Test Directory
| Test Code | ||||||||||||||||
| DULX | ||||||||||||||||
| Test Name | ||||||||||||||||
| Duloxetine, Quantitative, Whole Blood | ||||||||||||||||
| CPT Codes | ||||||||||||||||
| AMA 80332, CMS G0480 | ||||||||||||||||
| Expected Turnaround Time | ||||||||||||||||
| 5 - 7 days | ||||||||||||||||
| Clinical Utility | ||||||||||||||||
|
Duloxetine is used to treat symptoms of depression, neuropathic pain, fibromyalgia, and urinary stress incontinence. Routine drug monitoring is not indicated but may be useful for identifying patient compliance and/or toxicity. Useful in determining the use or abuse of Duloxetine. Testing includes identification and quantitation of:
|
||||||||||||||||
| Specimen and Container Info | ||||||||||||||||
*Preferred Specimen |
||||||||||||||||
| Processing and Submission Instructions | ||||||||||||||||
|
For forensic or legal purposes, submit specimen in a plastic evidence bag with a Chain-of-Custody Form. |
||||||||||||||||
| Transport Instructions | ||||||||||||||||
|
Transport to the laboratory refrigerated. |
||||||||||||||||
| Stability Requirements | ||||||||||||||||
|
||||||||||||||||
| Causes for Rejection | ||||||||||||||||
|
Specimens collected in separator tubes will be rejected. |
||||||||||||||||
| Methodology | ||||||||||||||||
| Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||||||
| Reference Intervals | ||||||||||||||||
|
||||||||||||||||
| Limitations | ||||||||||||||||
|
||||||||||||||||
| Performing Location | ||||||||||||||||
| Roble Road Core Laboratory | ||||||||||||||||
| Alternate Names | ||||||||||||||||
|
||||||||||||||||
| Testing Schedule | ||||||||||||||||
| Routine, 2 times per week | ||||||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.